← Back to all trials
Recruiting
NCT06422338
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Conditions: Infectious Disease, Febrile Illness, Child, Only
Sex: All
Ages: 2 Months – 60 Months
Healthy volunteers: No
Phase: NA
Enrollment: 5212
Sponsor: Barcelona Institute for Global Health
Location: CERMEL Centre de Recherches Médicales de Lambaréné Lambaréné Moyen-Ogooué Province
Summary
The overall aim of the study is to provide evidence that introducing novel biomarkers evaluation at triaging (first clinical assessment), in combination with IMCI-based guidelines (SoC), is a viable strategy to enhance rapid and accurate identification of febrile children at increased risk of life-threatening infections compared to IMCI-based strategies alone (SoC), and to demonstrate whether this results in enhanced decisions of admission/referral vs discharge, and enhanced overall health outcome of children with acute fever in sub-Saharan Africa.
Eligibility Criteria
Inclusion Criteria:
* Age ≥2 months and \
Source: ClinicalTrials.gov (NCT06422338). StuddyBuddy aggregates publicly available trial information.
